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Abstract 20 
We evaluated the effect of six azoles on embryonic development in the rat whole embryo 21 
culture (WEC). Using the total morphological scoring system (TMS), we calculated the ID10 22 
concentration (effective dose for 10% decrease in TMS). For evaluating gene specific 23 
responses, we combined previously and newly collected transcriptomics data of rat WEC 24 
exposed to a total of twelve azoles at their ID10 for 4 hours. Results revealed shared expressions 25 
responses in genes involved in the retinoic acid (RA) and sterol biosynthesis pathways, which 26 
are respectively representatives of developmental toxicity and targeted fungicidal action of the 27 
azoles. Azoles with more pronounced effects on the regulation of RA-associated genes were 28 
generally characterized as more potent embryotoxicants. Overall, compounds with strong sterol 29 
biosynthesis related responses and low RA related responses were considered as more 30 
favourable candidates, as they specifically regulated genes related to a desired target response. 31 
Among the identified sterol associated genes, we detected that methylsterol monooxygenase 1 32 
(Msmo1) was more sensitively induced compared to Cyp51, a classical biomarker of this 33 
pathway. Therefore, we suggest that Msmo1 could be a better biomarker for screening the 34 
fungicidal value of azoles. In summary, we conclude that the embryonic regulation of RA and 35 
sterol metabolic pathways could be indicators for ranking azoles as embryotoxicants and 36 
determining their drug efficacy.  37 
 38 
Keywords: Whole embryo culture; Toxicogenomics; Embryonic development; Azoles; 39 
Retinoic Acid; Sterol biosynthesis  40 
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1. Introduction 41 
Regulatory guidelines for the risk assessment of chemicals require relatively high 42 
numbers of experimental animals for reproductive and developmental toxicity testing (van der 43 
Jagt K. 2004). To reduce, refine and replace the use of laboratory animals, a variety of 44 
alternative assays has been developed over the past decades, including simple cell-line assays, 45 
organ cultures or more complicated whole embryo culture techniques and organs-on-a chip 46 
(Augustine-Rauch et al. 2010; Piersma 2006).  47 
An advanced in vitro model that mimics in vivo organogenesis and embryonic 48 
development is the rat whole embryo culture (WEC) technique (Piersma 2004; Robinson et al. 49 
2012c). It is a widely used technique for screening embryotoxicants by monitoring both 50 
neurulation and organogenesis during gestational days (GD) 10 to 12 (New et al. 1976). A 51 
variety of morphological endpoints is combined in the Total Morphological Score (TMS) 52 
(Piersma 2004). Applying the TMS in rat WEC, effects of chemicals on the embryonic growth 53 
and development can be studied both qualitatively and quantitatively.  WEC also enables the 54 
implementation of toxicogenomic-based approaches for mechanistic evaluation of the 55 
embryotoxic profile of xenobiotics. Gene signatures can predate and predict morphological 56 
consequences of toxic stimuli (Daston and Naciff 2010; Dimopoulou et al. 2017; Luijten et al. 57 
2010; Robinson et al. 2012a; Robinson et al. 2010). Furthermore, transcriptomics can be 58 
applied to identify biomarkers for detecting specific embryotoxic responses (Robinson et al. 59 
2012a). 60 
Azoles are antifungal agents for clinical and agricultural use. They have been designed 61 
to affect the Cyp51 enzyme, which catalyses the conversion of lanosterol to ergosterol on the 62 
fungal cell membrane, and leads to cell death when affected (Marotta and Tiboni 2010). In 63 
mammalian systems, Cyp51 is less sensitive to azoles, but still critical for the sterol 64 
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biosynthesis pathway. Moreover, azoles can induce many toxic responses in mammals by 65 
disturbing P450- mediated pathways and interfering with retinoic acid (RA) homeostasis (de 66 
Jong et al. 2011; Dimopoulou et al. 2017; Dimopoulou et al. 2016; Menegola et al. 2006). RA 67 
is crucial for maintaining balanced embryonic growth and differentiation, and Cyp26a1 is its 68 
key regulatory metabolic enzyme, catalysing the first step in the degradation of RA, (Piersma 69 
et al. ; Tonk et al. 2015). Previous in vivo and in vitro studies suggest that when rat embryos 70 
were exposed to either RA or azoles, similar teratogenic outcomes were observed, including 71 
craniofacial and axial defects (Cunningham and Duester 2015; Luijten et al. 2010; Piersma et 72 
al. ; Robinson et al. 2012c). Therefore, RA modulation may play a role in the developmental 73 
toxicity due to azole exposure.    74 
In our previous study (Dimopoulou et al. 2017), we combined the WEC technique with 75 
transcriptomic analysis for determining the effects of six azoles. Gene expression signatures of 76 
embryos exposed to the six tested azoles suggested that a RA-associated gene set corresponded 77 
with the toxicological mode of action while a sterol biosynthesis-related gene set represented 78 
the fungicidal activity of the azole compounds. In the present study, we assessed the relative 79 
embryotoxic potencies of six additional compounds - three known and three novel azoles - by 80 
performing a global gene expression profiling of these azoles. Subsequently, the gene 81 
expression data of all twelve compounds were evaluated in one combined analysis, focussing 82 
on the RA and sterol biosynthesis pathways. We aimed to define biomarkers related to the 83 
aforementioned pathways, as promising molecular endpoints for classifying the desired 84 
fungicidal as well as the embryotoxic responses of azoles, and correlating the latter with 85 
available in vivo embryotoxicity data.   86 
  87 
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2. Materials and Methods 88 
2.1.Animal care 89 
As described in our previous WEC studies (Dimopoulou et al. 2017; Dimopoulou et al. 2016), 90 
all the animal studies were approved and performed at the National Institute of Public Health 91 
and the Environment (RIVM) in concordance with European regulations. Wistar rats 92 
(HsdCpd:WU) (Harlan, The Netherlands) were housed at the RIVM Animal Care facility in a 93 
climate-controlled room with a 12h light cycle (04:00-16:00 dark). Water and food were 94 
provided ad libitum. After acclimating for 2 weeks, virgin female rats were housed with male 95 
rats for a 3-hour mating period (9:00-12:00, described as GD 0). Mated dams were afterwards 96 
individually housed. Rats were daily monitored for their general health condition during the 97 
period of the present study.  98 
2.2.Rat Whole Embryo Culture  99 
Following previous studies (Dimopoulou et al. 2017; Dimopoulou et al. 2016; Luijten et al. 100 
2010; Piersma 2004; Robinson et al. 2010), on GD 10, between 9:00 and 12:00 a.m., dams 101 
were euthanized by intracardiac injection of T61R (Intervet, The Netherlands). Rat embryos 102 
were immediately separated from the uterus. The peripheral trophoblastic cell zone and parietal 103 
yolk sac membrane were removed under the microscope leaving both the visceral yolk sac and 104 
ectoplacental cone intact. Embryos with 1-5 somites were further cultured, while only embryos 105 
with 2-4 somites were used for gene expression studies (Luijten et al. 2010). Embryos were 106 
separately cultured in flasks with 2 mL culture medium, containing 90% pregnant bovine serum 107 
and 10% rat serum (Biochrom, Berlin, Germany), diluted with 14% Hank’s solution (Gibco) 108 
and supplemented with 1.6 mg/mL D-glucose and 75 g/mL L-methionine (Sigma-Aldrich, 109 
Zwijndrecht, The Netherlands). The culture flasks were placed in rotating incubators, 110 
completely protected from light exposure and with stable internal temperature of 37.7oC. A 111 
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mixture of gas was supplied twice daily for 30 seconds, with increasing concentration of 112 
oxygen: on the first day (GD10) at 9:00 and 16:00 (5% O2, 5% CO2, 90% N2), on the second 113 
day (GD11) at 9:00 and 16:00 (20% O2, 5% CO2, 75% N2) and on the third day (GD12) at 9:00 114 
(40% O2, 5% CO2, 55% N2). 115 
2.3.Morphological assessment and statistical analysis of individual endpoints 116 
Embryos were cultured for 48 h (GD 10-12) and morphologically assessed according to the 117 
TMS system (Brown and Fabro 1981). Twenty morphological endpoints were included in this 118 
morphological assessment, which were sub-divided into two basic groups. These represented 119 
growth parameters (including yolk sac diameter, crown-rump length, head diameter and 120 
number of somites) and developmental/functional parameters, such as yolk sac and allantoic 121 
blood circulation, heart formation and heart beating, embryo- turning, caudal neural tube, optic 122 
and otic system, fore- and hind- limb, branchial arches, mandibular and maxillary process and 123 
the shape and size of somites. The TMS is a quantitative system for identifying any possible 124 
specific and selective embryotoxic effect of the tested compounds in rat embryos. Therefore, 125 
the sum of scores for each of the morphological endpoints was calculated for detecting any 126 
morphological alteration and for comparing with the time-matched controls. Within each 127 
exposure group, including also the vehicle control (DMSO), 8 rat embryos were evaluated. For 128 
normalizing the data and eliminating daily variation, the GD10 embryos within the same 129 
exposure group were derived from dams sacrificed on different days. Statistical analysis was 130 
performed using the parametric (Student’s t-test) and non-parametric (Mann-Whitney) 131 
(unpaired), two-sided, and with 95% confidence intervals. Due to high agreement between 132 
these approaches, the significance values deriving from the Student’s t-test are shown here. 133 
Images of the examined embryos (exposed for 48 hours to either DMSO or tested compounds) 134 
were obtained using an Olympus SZX9 camera at ×20 magnification and Olympus DP 135 
software.   136 
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2.4.Test compounds and exposure concentrations  137 
This study combines data of six known azole compounds from our previous publication 138 
(Dimopoulou et al. 2017) and additional data of three known and three new azoles derived 139 
from the present study. For the present study, the following three known and three novel azoles 140 
were tested in rat WEC for 48 hours (0-48h) in a range of concentrations with the lowest 141 
concentration inducing no morphological effect to the highest being the maximal achievable 142 
concentration in culture. The three known azoles were: fenarimol (FEN; CAS60168-88-9, 143 
purity 99.9 %, Sigma-Aldrich, Zwijndrecht, The Netherlands); propiconazole (PRO; 144 
CAS60207-90-1, purity 99.1 %, Sigma-Aldrich, Zwijndrecht, The Netherlands); and 145 
tebuconazole (TEB; CAS107534-96-3, purity 99.4 %, Sigma-Aldrich, Zwijndrecht) at 20, 60 146 
200 and 600 M. BASF SE (Ludwigshafen, Germany) kindly provided the three novel azole-147 
compounds (with purity > 95 %) and their chemical information is summarised in Table 1. 148 
B595 and B600 were tested at 60, 200 and 600 M; and B599 at 2, 6, 20 and 60 M. All the 149 
compounds were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich, Zwijndrecht, The 150 
Netherlands), and all embryos were exposed to a final DMSO concentration of 0.1%. As has 151 
been previously described, 0.1% DMSO did not significantly alter the morphology (4 and 48h) 152 
and has limited effects on gene expression after 4h of exposure (Dimopoulou et al. 2017; 153 
Robinson et al. 2010). The concentration at which rat WEC were exposed to conduct the gene 154 
expression analysis was in the same line of concept with our previous study (Dimopoulou et 155 
al. 2017) and calculated after completing the morphological assessment of rat embryos (48 156 
hours). Next, we calculated the concentration which results to 10% reduction of the control 157 
TMS (ID10) with both PROAST (Slob 2002) and Graphpad software (www.graphpad.com). 158 
For microarray analysis, rat WEC were exposed for 4 hours (0-4h) to the tested compounds at 159 
their ID10 values: FEN at 140µM, PRO at 220µM, TEB at 115µM, B595 at 180µM, B599 at 160 
5µM, and B600 at 110µM, as derived from the concentration response curves on TMS.            161 
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2.5.Whole embryo RNA isolation  162 
For transcriptomics, 4-hour cultured embryos were quickly scored on the basis of their somite 163 
number, their position in the yolk sac, neural tube developmental stage, crown-rump length 164 
and head diameter. They were then isolated from the yolk sac and ectoplacental cone, placed 165 
in 200μL RNAlater (Ambion, Austin, Texas), stored for one week at 4oC, and then stored for 166 
further processing at -80oC.  After the embryos were thawed on ice, they were separately 167 
homogenized by passing them 10 times though a 1mL syringe with a 26G needle. RNA was 168 
further isolated by using the RNeasy Micro Plus RNA isolation kit (CAS number 74034, 169 
Qiagen, the Netherlands) and manufacturer’s protocol. RNA was eluted with 14μM RNase-170 
free H2O and stored at -80
oC. Quantity and quality of the isolated RNA were measured with 171 
Nanodrop (Nanodrop Technologies Inc., Wilmington, Delaware) and 2100 BioAnalyzer 172 
(Agilent Technologies, Palo Alto, California). Samples with absorbance value between 1.9 and 173 
2.2 (ratio 260mm/280mm) and RNA integrity number (RIN) higher than 8 were further used 174 
for performing the microarray analysis.  175 
2.6.Microarray hybridization 176 
RNA hybridization and microarray experimentations were performed by the Dutch Service and 177 
Support Provider (MAD) of the University of Amsterdam, the Netherlands. In agreement with 178 
our previous publication (Dimopoulou et al. 2017), for every sample, RNA was amplified, 179 
biotin-labelled and hybridized to Affymetrix GeneChip HT RG-230 PM Array Plates 180 
according to the provided protocols by Affymetrix (Santa Clara, CA). After staining, the HT 181 
Array plate was read by the Affymetrix GeneChip® HT Scanner and analyzed by the 182 
Affymetrix GeneChip® Operating Software. For performing the aforementioned steps, the 183 
GeneTitan® Hybridization, Wash, and Stain Kit for 3’ IVT Arrays (cat no. 901530) was used. 184 
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In total, 56 arrays were further analysed (8 embryos per exposure group, 6 tested compounds 185 
and 1 control group). 186 
2.7.Microarray analysis and data processing 187 
The quality control (QC) and the normalization of the microarray data were performed using 188 
the Affymetrix array QC pipeline at ArrayAnalysis.org webpage (www.arrayanalysis.org) 189 
(Eijssen et al. 2013), designed by the Department of Bioinformatics in Maastricht University. 190 
Due to normal expected biological differences between the two studies ((Dimopoulou et al. 191 
2017) and present) and, consequently, to eliminate any experimental-specific gene responses, 192 
the raw data were separately normalized with their appropriate control for each study and 193 
accordingly processed. Raw microarray data were inspected for their quality by assessing the 194 
3´/5´ ratios for β-actin and GAPDH, RNA degradation, background intensity, signal quality 195 
and the probe-set homogeneity with NUSE (Normalized Unscaled Standard Error) and RLE 196 
(Relative Log Expression). The Affymetrix CEL files were further normalized by using the 197 
Robust Multichip Average (RMA) algorithm (Irizarry et al. 2003) and the Brainarray custom 198 
CDF version 19 probe set annotation 199 
(http://brainarray.mbni.med.umich.edu/Brainarray/default.asp) (Dai et al. 2005). In total, 200 
13,877 probe sets, each corresponding to an Entrez Gene ID, were further evaluated by 201 
performing a statistical analysis in R (www.R-project.org) and Microsoft Excel. Raw and 202 
normalized data were deposited in NCBI GEO (www.ncbi.nlm.nih.gov/geo/) under accession 203 
number GSE102082.  204 
2.8.Identification of significantly altered genes 205 
Normalized data were log transformed. For each exposure condition, gene expression data were 206 
compared to the appropriate control (each study has a separate control group), for calculating 207 
absolute average fold changes of individual gene expression. Differentially expressed genes 208 
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were identified by using ANOVA, using a p-value < 0.001 and a False Discovery Rate (FDR) 209 
of 10%, as stringency criteria. The statistical criteria were set similar to earlier published 210 
studies from our laboratory, and they partly determined the number of genes differentially 211 
expressed. The 53 genes, which were differentially expressed in at least one of the eight rat 212 
WEC samples from their respective exposure groups, were combined for further analysis. Gene 213 
expression responses were visualized using a heatmap combined with hierarchical clustering 214 
(Euclidean distance, Ward linkage) as well as Principal Component Analysis (PCA). Each bar 215 
in the heatmap represents the average of the gene expression in the experimental group 216 
compared to the respective control group of each study. 217 
2.9.Functional interpretation analysis of differentially expressed genes  218 
Following the concept of our previous study (Dimopoulou et al. 2017), functional annotation 219 
and overrepresentation analysis were performed using DAVID (https://david.ncifcrf.gov/) 220 
(Huang da et al. 2009) and literature data (Robinson et al. 2012b; Robinson et al. 2012c; Tonk 221 
et al. 2015). Here, we additionally applied the gene sets already identified from our previous 222 
study, which included genes participating in RA pathway, general development and the sterol 223 
biosynthesis pathway. Furthermore, we indicated three additional pathways that importantly 224 
identified genes belong to apoptosis, neural differentiation, and vessel formation. The 225 
combined gene expression data were summarized to absolute average fold changes per 226 
pathway. Next, the absolute average fold changes of genes of interest or of the whole pathway 227 
per exposure group were plotted against the compound concentration used. Finally, the 228 
absolute fold change of gene expression per RA and sterol biosynthesis pathways versus the 229 
used ID10 concentrations and the relative in vivo potencies of the tested compounds in rat 230 
embryos were plotted in a 3D plot using R.  231 
 232 
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2.10. In vivo data analysis  233 
In addition to previously derived in vivo data (Dimopoulou et al. 2017), a literature overview 234 
was performed to determine the in vivo developmental toxic profile of the three known  azoles. 235 
Applying the same criteria concerning the species, chemical exposure during specific GD and 236 
scheme of dosing range, we selected studies performed in rats orally exposed to the tested 237 
compounds during either GD6-15 or GD7-16 at multiple dose regimes. Studies with at least 238 
one control group and two dose groups were selected to allow analysis using the Benchmark 239 
Dose (BMD) approach. The BMD values were calculated based on the evidence of adverse 240 
skeletal changes or cleft palate formation, both selected as sensitive endpoints of in vivo 241 
developmental toxicity and specific for the tested group of chemicals. For some of the tested 242 
compounds, other morphological endpoints were considered for calculating the BMD values, 243 
dependent on the specificity of the malformations observed. A concentration-response curve 244 
was fitted to the data to determine the BMD for the selected benchmark response (BMR) for 245 
each tested azole. The BMD was defined as 10% additional incidence of adverse skeletal 246 
changes, cleft palate or any other relevant morphological alteration (BMD10). The BMD10 of 247 
each compound was calculated with BMD and PROAST software (Slob 2002) using 248 
dichotomous concentration-response models (quantal data). Among the several models that 249 
were fitted, the selection of the best model was determined based on the goodness of fit (p-250 
value>0.05). The in vivo prenatal developmental toxicity data for the three new azoles were 251 
provided by BASF. For the three novel compounds, given the available data, we proceeded 252 
with a qualitative in vivo potency ranking concept, which was adjusted and applied in our study, 253 
including also the known compounds. For implementing this approach of in vivo analysis, the 254 
profiles of the tested compounds were characterized as potent, moderate and weak or non-255 
potent.         256 
 257 
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3. Results 258 
3.1.Relative potency of azoles causing morphological alterations in rat WEC  259 
All azoles induced some form of developmental toxicity in a concentration-dependent manner 260 
in WEC (Figure 1, Table 2).  All newly tested compounds showed statistically significant 261 
effects on TMS at concentrations higher than 60 µM, except B599, which affected TMS at 20 262 
µM (Table 2). Caudal neural tube and somite formation were the most sensitive parameters for 263 
all compounds, except PRO. ID10 concentrations on TMS were calculated for all the tested 264 
compounds from Figure 1, after combining the current and our previous study (Dimopoulou et 265 
al. 2017). The decreasing potency ranking of the tested azoles was as follows: B599 > FLU ~ 266 
MCZ > KTZ > DFZ ~ B600 > TEB > FEN > TDF > B595 > PRO > PTZ with ID10s of 5, 25, 267 
40, 110, 115, 140, 150, 180, 220 and 250 µM, respectively.  268 
 269 
3.2.Significantly regulated genes across twelve azoles  270 
For studying the effect of the tested azoles on the transcriptome, embryos were exposed for 4 271 
hours on GD10 (0-4 hours of culture) to the ID10 concentration of each compound, as calculated 272 
from Figure 1. Somite formation was unaffected directly after all 4-hour exposures, indicating 273 
the absence of developmental delays at that stage  (Figure 2).   274 
For analysing the gene expression data, we compared each exposure group with the appropriate 275 
concurrent vehicle control and we applied the same stringency criteria as mentioned previously 276 
(p-value < 0.001 and FDR of 10%) (Dimopoulou et al. 2017). The combined data analysis 277 
revealed 53 genes that were statistically significantly regulated by at least one of the twelve 278 
azoles. As shown in Figure 3, embryonic exposure to KTZ and DFZ caused the highest number 279 
of statistically significant regulation of genes. On the other hand, MCZ and PTZ did not show 280 
statistically significantly regulated genes under the stringency criteria applied. 281 
The hierarchical clustering of the expression data of the 53 genes is illustrated as a heatmap 282 
(Figure 4). Pathway analysis using DAVID revealed enrichment of genes involved in six 283 
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pathways or processes; RA metabolism, general development, sterol biosynthesis, apoptosis, 284 
neural differentiation and vessel formation (Figure 4, right panel). For some of the genes, an 285 
overlap was observed among pathways. For example, Cyp26a1 appears both in the RA pathway 286 
and in the general development pathway.    287 
 288 
3.3.Quantitative gene expression changes in the RA and sterol biosynthesis pathways  289 
Within the six functional gene groups that were identified, the RA and sterol biosynthesis 290 
pathways were further analysed. As illustrated in Figure 5, the RA pathway showed a higher 291 
magnitude of regulation compared to the sterol biosynthesis pathway in embryos exposed to 292 
most compounds, excluding DFZ, MCZ and PTZ. DFZ induced regulation of both pathways 293 
to the same extent. MCZ and PTZ revealed a lack of response of both pathways under the 294 
significance thresholds applied.  295 
 296 
3.4.Gene expression changes observed throughout the sterol biosynthesis pathway  297 
The sterol biosynthesis pathway in mammalian systems consists of a cascade of enzymatic 298 
reactions initiated by fatty acid degradation. As in fungi, lanosterol is further converted to 299 
intermediate moieties, which are substrates for Cyp51, Msmo1 and Nsdhl for synthesizing 300 
cholesterol (Figure 6A).  301 
We numbered the enzymes included on the microarray in the order of appearance in the sterol 302 
biosynthesis pathway (Figure 6A) and plotted their gene expression changes by the different 303 
azoles (Figure 6B). Msmo1 showed the highest gene expression regulation after exposure to 304 
the tested compounds, except for PTZ, TEB and B599 (Figure 6B). The greatest effect on the 305 
regulation of Msmo1 was observed in rat embryos exposed to DFZ (1.96), KTZ (1.82) and TDF 306 
(1.55). The remaining genes were regulated in a relatively similar expression ratio, with the 307 
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exception of Dhcr7 in the case of PRO, which reached almost the same level of expression of 308 
Msmo1 (Figure 6B), at a fold change of 1.5. 309 
 310 
3.5.A general comparison of in vivo and in vitro data 311 
In vivo studies on rat embryos, in which the developmental toxic profile of the twelve azoles 312 
was tested, were further analysed and the BMD10 value of each compound was calculated 313 
(Table 3). With these data, we performed a potency ranking based on the calculated BMD10 314 
concentration, which was based on an overall assessment of doses-dependent embryotoxic 315 
effects. The BMD10 was derived based on the most sensitive endpoint, which might differ 316 
between compounds. Abnormalities might include skeletal defects, cleft palate, and absence of 317 
renal papilla or hydronephrosis. For the three novel compounds B595, B599 and B600, in vivo 318 
prenatal developmental toxicity data were provided by BASF SE laboratories. The potency 319 
ranking of these compounds was qualitatively performed based on limited dose-response 320 
information (Li et al. 2016) and resulted in the following order: B599 > B600 > B595. Based 321 
on the in vivo qualitative and quantitative (where applicable) data, we allocated the twelve 322 
tested compounds into one of three developmental toxicity potency groups. The most potent 323 
compounds were B599, FLU and KTZ. The moderately  embryotoxic compounds in vivo were 324 
B600, FEN, MCZ, TDF and TEB, while the weak or non-potent compounds were B595, DFZ, 325 
PRO and PTZ (Table 3). Table 3 contains also our in vitro data of the twelve azoles, including 326 
the ID10 concentrations based on TMS.  327 
Figure 7 shows a comparison of RA pathway regulation (x-axis), ID10 in WEC (y-axis) and 328 
sterol biosynthesis pathway regulation (z-axis) with in vivo potency groups (Table 3, bar 329 
colour). B599, FLU and KTZ, the potent developmental toxicants profile both in vivo (red bars) 330 
and in vitro (low ID10 in the WEC assay), tended to have a more pronounced effect on 331 
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regulation of the RA pathway (Figure 7). The compounds with moderate developmental toxic 332 
profile (yellow bars) showed a more limited effect on the RA and sterol biosynthesis pathways. 333 
MCZ was classified as a moderate compound in the in vivo situation, which was not in 334 
agreement with the morphological assessment of embryos in the WEC assay. Additionally, the 335 
transcriptomic data revealed an absence of gene-responses in embryos exposed to this azole 336 
(Figure 3). These data were similar to the transcriptome data obtained from embryos exposed 337 
to PTZ, which was selected as a non-toxic compound for our study. In contrast, PRO, a weak 338 
embryotoxicant in vivo and in vitro, presented a strong RA-related profile, similar to TDF. DFZ 339 
and KTZ conceded a comparable regulation of the sterol biosynthesis pathway, but DFZ did 340 
not significantly disturb the RA-related genes. For the remainder of the compounds, we found 341 
mixed responses, with a stronger regulation of the RA pathway than of the sterol biosynthesis 342 
pathway (Figure 7).   343 
  344 
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4. Discussion 345 
In the present study, azoles induced concentration dependent developmental toxic 346 
responses in rat WEC, including abnormalities in neural tube closure, formation of the 347 
branchial arches and development of the otic cup. Embryos exposed in vivo to the same azoles 348 
demonstrated commonly observed abnormalities for triazoles , including cleft palate 349 
(Tachibana 1987) and skeletal abnormalities (Becker 1988; Giknis 1987; Ito 1976; Lochry 350 
1987; Stahl 1997; Unger 1982), or hydronephrosis (Hoffman 1980) and abnormalities in the 351 
urogenital system (Lamontia CL 1984). It should be noted that some of these abnormalities are 352 
induced in vivo at stages beyond the WEC developmental period. The pattern of abnormalities 353 
due to either in vivo or in vitro exposure to azoles is similar to that observed after exposure to 354 
RA (Luijten et al. 2010; Robinson et al. 2012c). This observation is supportive of an 355 
involvement of the RA pathway in the developmental toxicity of azoles. Comparing in vitro 356 
ID10 with the in vivo BMD10 levels (Table 3), we concluded that potency ranking in the WEC 357 
was largely similar to the potency ranking in the in vivo situation.  358 
We identified 53 genes statistically significantly regulated (ANOVA, p-value<0.001, 359 
FDR 10%) by at least one of the compounds, which were further categorized into six functional 360 
gene-groups. We further analysed the responses of genes associated with the sterol biosynthesis 361 
and RA pathways, due to their crucial role for determining the fungicidal mode of action (sterol 362 
biosynthesis pathway) and the embryotoxic potency (RA pathway) of the tested compounds. 363 
Among the regulated sterol biosynthesis related genes, Msmo1 showed the highest 364 
increase in expression, after embryonic exposure to KTZ and DFZ, as well as TDF and PRO. 365 
Despite the fact that mammalian systems are less sensitive than fungal systems to azoles 366 
(Trosken et al. 2006), the expression of sterol related genes in both biological systems 367 
determines azoles’ fungicidal activity. The observed significant induction of Msmo1 (or its 368 
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synonym, Sc4mol) was also identified in previous studies in the rat WEC (Dimopoulou et al. 369 
2017; Robinson et al. 2012b), as well as in the zebrafish test (ZET) (Hermsen et al. 2012) and 370 
Embryonic Stem Cell Test (EST) (van Dartel et al. 2011). Additionally, considering that the 371 
expression pattern of all the individual sterol related genes was constant among the tested 372 
compounds (Figure 6B), we suggest that Msmo1 could be a more sensitive biomarker compared 373 
to the already characterized biomarker Cyp51 (Marotta and Tiboni 2010) for studying the 374 
fungicidal activity. However, for concluding about the extent of each gene’s specific 375 
importance in the sterol biosynthesis pathway, studies on the level of the metabolome are 376 
needed. Msmo1 is involved in an oxidation-reduction process, while it is also associated with 377 
malformations, such as microcephaly and congenital cataract, which could be linked with its 378 
extra role in the central nervous system development (CNS), and especially in the midbrain 379 
neurogenesis (He et al. 2011). Pinto at al. (Pinto et al. 2016) described that Msmo1 transcription 380 
is activated by the liver X receptors (LXR), which are binding to the retinoid X receptors 381 
(RXR), a connection that could be further associated with RA. Additionally, Srebp 382 
transcriptional factors regulate the cholesterol biosynthesis pathway in mammalian systems, 383 
via interacting with the binding sites of Hmgcr and Fdft1 in the mevalonate arm in the 384 
beginning of the pathway (Mazein et al. 2013). Srebp interacts directly with LXR and therefore 385 
may indirectly regulate genes in the sterol biosynthesis pathway (Horton 2002; Pinto et al. 386 
2016).  387 
Additionally, we observed that the potent in vivo and in vitro embryotoxicants, as well 388 
as the moderate TDF and the weak PRO, altered the expression of RA-related genes in a similar 389 
manner. The commonly highest upregulated gene was Cyp26a1, which is upregulated for 390 
metabolizing excess level of RA (Rhinn and Dollé 2012). Therefore, we suggest that the 391 
overexpression of the RA pathway could be the underlying mechanism of induced 392 
developmental toxicity of azoles in the rat WEC. Consequently, the application of RA-related 393 
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biomarkers is valuable for distinguishing highly potent embryotoxicants within the same class 394 
of chemicals. 395 
MCZ, a compound with potent in vitro and moderate in vivo embryotoxic potency, 396 
lacked a statistically significant response on the level of transcriptome in our combined 397 
analysis.  This suggests that transcriptomics may not be the optimal method to detect the 398 
embryotoxic mode of action of MCZ. Apoptosis, an additionally identified functional gene 399 
group, was extensively regulated by the azoles that showed the highest response of RA-related 400 
genes. Interestingly, similar to the strong in vitro embryotoxicants FLU, KTZ and B599, MCZ 401 
did show enhanced expression of Ngfr, an apoptosis related gene (Figure 4). Ngfr is associated 402 
with neuron differentiation in the brain region (Do et al. 2016), while it has been also suggested 403 
to be mediator for thyroid hormone activation (Porterfield 2000) and a negative regulator of 404 
angiogenesis (Parsi et al. 2012). Another apoptosis related strong effect was identified on the 405 
expression of Fam101a, which is localized in the midbrain and forebrain of 5-somite stage 406 
embryos (Hirano et al. 2005; Mizuhashi et al. 2014), while it is involved in the bone maturation 407 
and interacts with RA (NCBI 2013). Furthermore, Txnip, a general biomarker of stress 408 
responses, is related with the dysregulation of cell division (Dunn et al. 2010; Patwari et al. 409 
2006). The similarity of expression among genes of RA and apoptosis pathways could support 410 
our hypothesis that RA related responses are directly linked to developmental toxic responses 411 
and, therefore, could justify the consequent embryotoxicity of the corresponding azoles. 412 
Moreover, Lhx1, the most pronounced expressed gene among the neural differentiation 413 
related genes, was remarkably affected in WEC exposed to B599, FLU, KTZ and TDF, which 414 
are among the most potent compounds. Lhx1 has been also suggested to be indirectly associated 415 
with RA and RA-related morphological alterations. It is localized in the brain and has been 416 
shown to interact with development related genes and transcriptional factors (Furuyama et al. 417 
1994), such as the Hox and Pax genes, and therefore, it could be indirectly correlated with the 418 
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activation of the Gata and Wnt signalling pathways (Costantini and Kopan 2010; Hevner et al. 419 
2002; Pratt et al. 2000). Karavanov et al. (Karavanov et al. 1998) have also described its 420 
additional role in the kidney development during embryonic development and in later stages 421 
for maintaining the function of the ureteric bud.  422 
Embryos exposed to azoles with high ID10 concentrations disclosed a notable 423 
downregulation of a set of genes, which could explain the sensitivity of the WEC system 424 
compared to the in vivo screening in ranking DFZ and PRO. The highest regulation of Ifrd1, 425 
which participates in neuron differentiation and general development pathways (Figure 4), 426 
could be associated with cellular stress in multicellular organisms according to Zhao et al. 427 
(Zhao et al. 2010). In those embryos, we also observed a significant accompanied 428 
downregulation of both Arrdc4, a protein that regulates the ubiquitin-protein transferase 429 
activity (Mackenzie et al. 2016), and Txnip (Figure 4). Txnip is a member of the alpha arrestin 430 
protein family (to which Arrdc4 belongs too), however the exact mechanism of collaboration 431 
of these two genes has not been elucidated yet (Fishilevich et al. 2017).  432 
To summarize, we investigated the potency ranking of twelve azoles in the rat WEC, 433 
the vast majority of which was in line with the in vivo potency ranking. We also studied the 434 
toxicological and fungicidal mode of action of the selected compounds on the level of 435 
transcriptome using the set of biomarkers that has been previously selected (Dimopoulou et al. 436 
2017). We concluded that the most potent embryotoxicants, both in vivo and in vitro, revealed 437 
an overexpression of genes that participated in RA related pathways, and were associated with 438 
apoptosis and stress responses. Moreover, we identified responses of genes that participated in 439 
the sterol biosynthesis pathway and, therefore, related to the fungicidal mode of action. We 440 
found that Msmo1 was a more sensitive biomarker for screening the functional efficacy of 441 
azoles compared to Cyp51, which could improve the in vitro assessment of existing and future 442 
antifungal chemicals. 443 
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Tables 619 
 620 
Table 1: Chemical information of the three novel azoles tested in the present study. 621 
Code Structure Molecular weight (g/mol) 
B595 
 
415.4 
B599 
 
418.5 
B600 
 
434.3 
 622 
 623 
  624 
26 
 
Table 2: Overview of morphological effects of the tested azoles in the rat WEC assay. 625 
Compound 
Concentration 
(μM) 
TMS CRL (mm) S48h – S0h FORE MID HIND CAUD OTIC OPTIC BRAN MAND-MAX SOM HEART 
DMSO 0 65.8±10.7 4±0.11 25±0.83 - - - - - - - - - - 
FEN 
20 65.9±1.74 4.1±0.09 24±0.92 - - - - - - - - - - 
60 63.8±1.62 4.0±0.27 24±1.28 - - - - - - - - - - 
200 
51.7±7.71*
** 
3.7±0.19 
20±2.00*
** 
- - - ** * - * * ** - 
600 
19.8±3.35*
*** 
2.3±0.52*** # **** **** **** *** **** **** **** **** **** **** 
PRO 
20 65.2±1.71 4.0±0.16 25±0.92 - - - - - - - - - - 
60 64.4±1.75 4.1±0.09 24±0.92 - - - - - - - - - - 
200 60.0±5.04* 3.8±0.18 23±1.13* - - - - - - * - - - 
600 
31.8±8.24*
*** 
3.1±0.32*** # **** **** **** **** *** **** **** ** **** **** 
TEB 
20 65.7±1.07 4.2±0.14 24±0.52 - - - - - - - - - - 
60 63.6±2.03 4.0±0.28 23±0.93 - - - - - - - - - - 
200 
52.4±5.22*
* 
3.7±0.16 19±2.00* - - - ** - - * - ** - 
600 
15.3±20.5*
*** 
1.7±0.10* # **** **** **** *** **** **** **** **** **** **** 
B595 
60 66.2±0.84 3.9±0.17 24±1.19 - - - - - - - - - - 
200 57.7±4.24* 3.7±0.19* 22±1.93* - - - * - - - - ** - 
600 
27.9±12.12
*** 
2.9±0.58***
* 
14±4.96*
*** 
**** **** **** *** *** *** **** *** **** **** 
B599 
2 65.9±0.92 4.0±0.19 24±0.00 - - - - - - - - - - 
6 59.8±3.60 4.0±0.14 23±0.71 - - - - - - - - - - 
20 
45.3±7.10*
* 
3.7±0.16 
18±1.28*
** 
** - - *** ** - ** - ** - 
60 
24.4±3.57*
*** 
2.7±0.23*** 
12±3.78*
*** 
**** *** **** *** **** **** **** *** **** **** 
B600 
60 65.1±1.32 3.9±0.37 24±0.64 - - - - - - - - - - 
200 50.3±1.60* 3.5±0.23* 23±0.92* - - * ** - - * * - * 
600 
19.0±3.67*
*** 
1.9±0.50***
* 
# **** **** **** *** **** **** **** **** **** **** 
Each number represents a mean ± SD (N=8, Student’s t-test: * p < 0.05, ** p < 0.005, *** p < 0.0005, **** p < 0.0001). CRL: crown-rump length; S48h- S0h: number of somites that formed during 626 
the culture period of rat WEC; FORE: forebrain; MID: midbrain; HIND: hindbrain; CAUD: caudal neural tube; OTIC: otic system; OPTIC: optic system; BRAN: branchial arches; MAND-MAX: 627 
mandibular and maxillary process; SOM: quality of somites and HEART: heart; “#”: could not be measured  628 
27 
 
Table 3: Overview of in vivo and in vitro developmental toxicity data of twelve azoles. 629 
Compound 
in vitro WEC in vivo 
ID10 
(µM) 
BMD10 
(µmol/kg) 
Potency Group 
B599 5 - Potent 
FLU 25 9.1 (Lamontia CL 1984) Potent 
MCZ 25 258.3 (Ito 1976) Moderate 
KTZ 40 20.1 (Tachibana 1987) Potent 
B600 110 - Moderate 
DFZ 110 596.5 (Lochry 1987) Weak 
TEB 115 275.8 (Becker 1988) Moderate 
FEN 140 88.5 (Hoffman 1980) Moderate 
TDF 150 91.5 (Unger 1982) Moderate 
B595 180 - Weak 
PRO 220 386.7 (Giknis 1987) Weak 
PTZ 250 917.8 (Stahl 1997) Weak 
 630 
  631 
28 
 
Figures 632 
 633 
 634 
Figure 1: Total Morphological Score (TMS) concentration-responses of twelve azoles in the 635 
rat WEC after 48 hours of exposure. Each point represents a mean ± SD (N=8). The curves for 636 
the six compounds in the left side list were reproduced from (Dimopoulou et al. 2017). 637 
  638 
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 639 
 640 
Figure 2: Somitogenesis in rat embryos exposed for 4 hours to six azoles at their ID10 641 
concentration, collected for whole transcriptome analysis. Individual data with mean ± SD 642 
are plotted (N=8 embryos per group).  643 
 644 
Figure 3: Number of genes statistically significantly regulated by each azole at the ID10 on 645 
TMS among the tested azoles (p-value<0.001 and FDR 10%). 646 
 647 
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 648 
Figure 4: Hierarchical clustering of the average gene expression change in rat WEC by twelve 649 
azoles (N=8, p-value<0.001 and FDR 10%), with which 53 genes were identified as 650 
statistically significantly regulated by at least one of the compounds. Right panel: gene 651 
functionality in six pathways: RA (RA), general development (DEV), sterol biosynthesis (STE), 652 
apoptosis (APO), neural differentiation (NEU) and vessel formation (VES). Colors indicate 653 
changes to vehicle. Red, up-regulation; green, down-regulation; yellow, unchanged.     654 
 655 
 656 
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 657 
Figure 5: Quantitative gene expression changes, related to the RA and sterol biosynthesis 658 
pathways, of twelve azoles in the rat WEC. 659 
 660 
  661 
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A      662 
 663 
B 664 
 665 
Figure 6: A. The sterol biosynthesis pathway in the Rattus norvegicus, including the main 666 
intermediate moieties and the contributing enzymes adapted from www.wikipathways.org 667 
(Kutmon et al. 2016) and (Santori et al. 2015). B. The quantitative regulation of the genes that 668 
participate in the sterol biosynthesis pathway in rat WEC exposed to twelve azoles. 669 
 670 
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 671 
Figure 7: Correlation of in vivo and in vitro in the rat WEC data for twelve tested azoles. Bars 672 
with red, yellow and green colour indicate in a qualitative way the potent, moderate and weak 673 
or non-toxic in vivo profile of these azoles. The length of the bars represents the in vitro ID10 674 
concentration (y-axis).    675 
 676 
